ICH M13A published [Design Issues]

posted by ElMaestro  – Denmark, 2024-07-31 16:14 (342 d 17:04 ago) – Posting: # 24114
Views: 5,936

Hi Zuzana,

the ICH document was written in a generic fashion, it does not take into consideration specific cases like yours. This fully justifies a deviation from the guidance. It is for that reason that I think EU regulators would suggest to dose as per SmPC and not as per ICH guidance if you ask for scientific advice. So that is what I would lean towards.

Gut feeling only.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,694 registered users;
76 visitors (0 registered, 76 guests [including 26 identified bots]).
Forum time: 09:19 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5